Gentile Kimberly — SEC insider filings

SEC reporting owner CIK 1704186. 13 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2020-10-09 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Biohaven Pharmaceutical Holding Co Ltd. (BHVN)SVP, Clinical Operations6—3 legs · 23,500 sh · $1,794,08234
Biohaven Ltd. (BHVN)SVP, Clinical Operations7——54

Insider filings — Gentile Kimberly

FiledFormIssuerReported transactionsSource
2026-09-174Biohaven Ltd. (BHVN)Grant/award (A): 1,000 (derivative) @ $0EDGAR
2026-03-034Biohaven Ltd. (BHVN)Grant/award (A): 175,000 (derivative) @ $0EDGAR
2026-01-074Biohaven Ltd. (BHVN)Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,956 @ $9.93 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2025-01-074Biohaven Ltd. (BHVN)Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,956 @ $38.64 · Grant/award (A): 91,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2024-01-044Biohaven Ltd. (BHVN)Grant/award (A): 96,250 (derivative) @ $0EDGAR
2023-11-064Biohaven Ltd. (BHVN)Grant/award (A): 78,750 (derivative) @ $0EDGAR
2022-10-054Biohaven Ltd. (BHVN)Other (J): 5,826 @ $0 · Other (J): 6,500 @ $0 · Other (J): 3,750 @ $0 · Other (J): 1,875 @ $0 · Option exercise (M): 387 @ $6.37 · Option exercise (M): 12,612 @ $6.37 · +36 moreEDGAR
2022-10-034Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Disposition to issuer (D): 11,653 @ $148.50 · Disposition to issuer (D): 13,000 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 3,750 (derivative) · Disposition to issuer (D): 775 (derivative) · Disposition to issuer (D): 25,225 (derivative) · +10 moreEDGAR
2022-01-074Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,800 @ $123.86 · Option exercise (M): 3,750 (derivative) @ $0 · Grant/award (A): 26,000 (derivative) @ $0 · Grant/award (A): 13,000 (derivative) @ $0EDGAR
2021-11-264Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,738 @ $115.55 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2021-01-084Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,747 @ $83.38 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2020-11-274Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Option exercise (M): 3,750 @ $0 · Tax withholding (F): 1,701 @ $90.14 · Option exercise (M): 3,750 (derivative) @ $0EDGAR
2020-10-094Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Option exercise (M): 23,500 @ $9.29 · Sale (S): 5,261 @ $75.62 · Sale (S): 15,781 @ $76.42 · Sale (S): 2,458 @ $77.42 · Sale (S): 23,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1704186 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs